Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoadjuvant Operable Breast Cancer × Fluorouracil × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 105 Colorectal Neoplasms 8 Triple Negative Breast Neoplasms 6 Neoplasms 6 Stomach Neoplasms 5 Ovarian Neoplasms 5 Inflammatory Breast Neoplasms 5 Neoplasm Metastasis 4 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Head and Neck Neoplasms 3 Esophageal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Multiple Myeloma 2 Lung Neoplasms 2 Hematologic Neoplasms 2 Endometrial Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Renal Cell 2 Breast Neoplasms, Male 2 Women With Primary Breast Cancer 1 Tracheal Neoplasms 1 Thyroid Neoplasms 1 Thrombocytosis 1 Solitary Pulmonary Nodule 1 Small Cell Lung Carcinoma 1 Sarcoma 1

Interventions

palbociclib 1 Letrozole 1 Fluorouracil 1 Epirubicin 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02400567 2022-03-15

NeoPAL

UNICANCER

Phase 2 Completed

Neoadjuvant Operable Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡